Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 128

    1.

    Oral thymic extract for chronic hepatitis C in patients previously treated with interferon. A randomized, double-blind, placebo-controlled trial.

    Raymond RS, Fallon MB, Abrams GA.

    Ann Intern Med. 1998 Nov 15;129(10):797-800.PMID: 9841585 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Interferon beta 1a versus interferon beta 1a plus ribavirin for the treatment of chronic hepatitis C in Chinese patients: a randomized, placebo-controlled trial.

    Han Q, Liu Z, Kang W, Li H, Zhang L, Zhang N.

    Dig Dis Sci. 2008 Aug;53(8):2238-45. Epub 2007 Dec 13.PMID: 18080763 [PubMed - indexed for MEDLINE]Related articles

    3.

    Antioxidant therapy for chronic hepatitis C after failure of interferon: results of phase II randomized, double-blind placebo controlled clinical trial.

    Gabbay E, Zigmond E, Pappo O, Hemed N, Rowe M, Zabrecky G, Cohen R, Ilan Y.

    World J Gastroenterol. 2007 Oct 28;13(40):5317-23.PMID: 17879400 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial.

    Di Bisceglie AM, Conjeevaram HS, Fried MW, Sallie R, Park Y, Yurdaydin C, Swain M, Kleiner DE, Mahaney K, Hoofnagle JH.

    Ann Intern Med. 1995 Dec 15;123(12):897-903.PMID: 7486483 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Amantadine therapy for chronic hepatitis C.

    Smith JP, Riley TR 3rd, Devenyi A, Bingaman SI, Kunselman A.

    J Gen Intern Med. 2004 Jun;19(6):662-8.PMID: 15209605 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Interferon and amantadine in naive chronic hepatitis C: a double-blind, randomized, placebo-controlled trial.

    Helbling B, Stamenic I, Viani F, Gonvers JJ, Dufour JF, Reichen J, Cathomas G, Steuerwald M, Borovicka J, Sagmeister M, Renner EL; Investigators of the Swiss Association for the Study of the Liver.

    Hepatology. 2002 Feb;35(2):447-54.PMID: 11826422 [PubMed - indexed for MEDLINE]Related articles

    7.

    Efficacy and tolerance of interferon-alpha(2b) in the treatment of chronic hepatitis C virus infection in haemodialysis patients. Pre- and post-renal transplantation assessment.

    Campistol JM, Esforzado N, Martínez J, Roselló L, Veciana L, Modol J, Casellas J, Pons M, de Las Cuevas X, Piera J, Oliva JA, Costa J, Barrera JM, Bruguera M.

    Nephrol Dial Transplant. 1999 Nov;14(11):2704-9.PMID: 10534516 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence.

    Bizollon T, Ahmed SN, Radenne S, Chevallier M, Chevallier P, Parvaz P, Guichard S, Ducerf C, Baulieux J, Zoulim F, Trepo C.

    Gut. 2003 Feb;52(2):283-7.PMID: 12524414 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Pre-treatment with prednisolone does not improve the efficacy of subsequent alpha interferon therapy in chronic hepatitis C.

    Guilera M, Forns X, Torras X, Enríquez J, Coll S, Solà R, Morillas R, Planas R, Ampurdanès S, Soler M, Costa J, Sáiz JC, Sánchez-Tapias JM, Rodés J.

    J Hepatol. 2000 Jul;33(1):135-41.PMID: 10905597 [PubMed - indexed for MEDLINE]Related articles

    10.

    Changes in serum hepatitis C virus RNA in interferon nonresponders retreated with interferon plus ribavirin: a preliminary report.

    Nyberg L, Albrecht J, Glue P, Gianelli G, Zambas D, Elliot M, Conrad A, McHutchison J.

    J Clin Gastroenterol. 1999 Jun;28(4):313-6.PMID: 10372927 [PubMed - indexed for MEDLINE]Related articles

    11.

    Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: a placebo-controlled trial.

    Berg T, Kronenberger B, Hinrichsen H, Gerlach T, Buggisch P, Herrmann E, Spengler U, Goeser T, Nasser S, Wursthorn K, Pape GR, Hopf U, Zeuzem S.

    Hepatology. 2003 Jun;37(6):1359-67.PMID: 12774015 [PubMed - indexed for MEDLINE]Related articles

    12.

    A randomized, controlled trial of maintenance interferon therapy for patients with chronic hepatitis C virus and persistent viremia.

    Shiffman ML, Hofmann CM, Contos MJ, Luketic VA, Sanyal AJ, Sterling RK, Ferreira-Gonzalez A, Mills AS, Garret C.

    Gastroenterology. 1999 Nov;117(5):1164-72.PMID: 10535880 [PubMed - indexed for MEDLINE]Related articles

    13.

    Randomized, double-blind, placebo-controlled trial of interferon alfa2a with and without amantadine as initial treatment for chronic hepatitis C.

    Zeuzem S, Teuber G, Naumann U, Berg T, Raedle J, Hartmann S, Hopf U.

    Hepatology. 2000 Oct;32(4 Pt 1):835-41.PMID: 11003631 [PubMed - indexed for MEDLINE]Related articles

    14.

    Long-term treatment of chronic hepatitis C with ursodeoxycholic acid: influence of HCV genotypes and severity of liver disease.

    Lirussi F, Beccarello A, Bortolato L, Morselli-Labate AM, Crovatto M, Ceselli S, Santini G, Crepaldi G.

    Liver. 1999 Oct;19(5):381-8.PMID: 10533795 [PubMed - indexed for MEDLINE]Related articles

    15.

    Randomised, double blind, placebo controlled trial of interferon, ribavirin, and amantadine versus interferon, ribavirin, and placebo in treatment naïve patients with chronic hepatitis C.

    Thuluvath PJ, Maheshwari A, Mehdi J, Fairbanks KD, Wu LL, Gelrud LG, Ryan MJ, Anania FA, Lobis IF, Black M.

    Gut. 2004 Jan;53(1):130-5.PMID: 14684587 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    [Treatment of chronic hepatitis C by bicyclum, a randomized double-blind placebo controlled trial]

    Yao G, Ji Y, Zhou X, Wang Q, Wu W.

    Zhonghua Yi Xue Za Zhi. 2002 Jul 25;82(14):958-60. Chinese. PMID: 12181088 [PubMed - indexed for MEDLINE]Related articles

    17.

    Combination of interferon and ribavirin in chronic hepatitis C: re-treatment of nonresponders to interferon.

    Di Bisceglie AM, Thompson J, Smith-Wilkaitis N, Brunt EM, Bacon BR.

    Hepatology. 2001 Mar;33(3):704-7.PMID: 11230751 [PubMed - indexed for MEDLINE]Related articles

    18.

    Comparative effects of different doses of ribavirin plus interferon-alpha2b for therapy of chronic hepatitis C: results of a controlled, randomized trial.

    Bonkovsky HL, Stefancyk D, McNeal K, Banner BF, Liu Q, Zucker GM, Israel J, Stagias J, Colker J.

    Dig Dis Sci. 2001 Oct;46(10):2051-9.PMID: 11680575 [PubMed - indexed for MEDLINE]Related articles

    19.

    Pilot study of triple antiviral therapy for chronic hepatitis C in interferon alpha non-responders.

    Brillanti S, Foli M, Di Tomaso M, Gramantieri L, Masci C, Bolondi L.

    Ital J Gastroenterol Hepatol. 1999 Mar;31(2):130-4.PMID: 10363198 [PubMed - indexed for MEDLINE]Related articles

    20.

    A multicenter, randomized, controlled trial of interferon alfacon-1 compared with alpha-2a-interferon in Chinese patients with chronic hepatitis C virus infection.

    Yao GB, Fu XX, Tian GS, Xu DZ, Hao LJ, Huangfu YS, Su CX.

    J Gastroenterol Hepatol. 2000 Oct;15(10):1165-70.PMID: 11106097 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data